Current Report Filing (8-k)
January 24 2017 - 4:32PM
Edgar (US Regulatory)
UNITED
STATES
SECURITIES
AND EXCHANGE COMMISSION
Washington,
D.C. 20549
FORM
8-K
CURRENT
REPORT
Pursuant
to Section 13 or 15(d) of the Securities Exchange Act of 1934
Date
of Report (Date of earliest event reported):
January 24, 2017
AMEDICA
CORPORATION
(Exact name of registrant as specified in its charter)
Delaware
|
|
001-33624
|
|
84-1375299
|
(State
or other jurisdiction of
|
|
(Commission
|
|
(IRS
Employer
|
incorporation)
|
|
File
Number)
|
|
Identification
No.)
|
1885
West 2100 South
Salt
Lake City, UT 84119
(Address
of principal executive offices, including Zip Code)
Registrant’s
telephone number, including area code:
(801) 839-3500
N/A
(Former name or former address, if changed since last report)
Check
the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant
under any of the following provisions:
[ ]
|
Written
communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
|
|
|
[ ]
|
Soliciting
material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
|
|
|
[ ]
|
Pre-commencement
communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
|
|
|
[ ]
|
Pre-commencement
communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))
|
Item 1.01
|
Entry
into a Material Definitive Agreement
|
On
January 24, 2017, Amedica Corporation closed (the “Closing”) its previously announced underwritten public offering
(the “Offering”) of 8,900,000 shares of its common stock and warrants to purchase 4,005,000 shares of its common stock.
In connection with the Closing, the Company entered into a warrant agency agreement with American Stocker Transfer & Trust
Co. (“AST”), pursuant to which AST will serve as warrant agent for the warrants issued in the Offering. A copy of
the Warrant Agency Agreement is attached to this report as Exhibit 10.1 and incorporated herein by reference.
Item
9.01
|
Financial
Statements and Exhibits.
|
Exhibit
No.
|
|
Description
|
|
|
|
10.1
|
|
Warrant
Agency Agreement dated January 24, 2017
|
SIGNATURES
Pursuant
to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf
by the undersigned hereunto duly authorized.
|
|
|
AMEDICA
CORPORATION
|
|
|
|
|
|
Date:
|
January
24, 2017
|
|
By:
|
/s/
B. Sonny Bal
|
|
|
|
|
B.
Sonny Bal
|
|
|
|
|
Chief
Executive Officer
|
EXHIBIT
INDEX
Exhibit
No
.
|
|
Exhibit
Description
|
|
|
|
10.1
|
|
Warrant
Agency Agreement dated January 24, 2017
|
AMEDICA CORP (NASDAQ:AMDA)
Historical Stock Chart
From Aug 2024 to Sep 2024
AMEDICA CORP (NASDAQ:AMDA)
Historical Stock Chart
From Sep 2023 to Sep 2024